<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1916</article-id><article-id pub-id-type="doi">10.32687/1561-5936-2026-30-2-140-143</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Some aspects of the development of the pharmaceutical industry in the Russian Federation: challenges, trends and prospects</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Avanesova</surname><given-names>Rita R.</given-names></name><bio></bio><email>margarita-ava@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Romanova</surname><given-names>Elena V.</given-names></name><bio></bio><email>lenina_ev@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Slyusarenko</surname><given-names>Elvira E.</given-names></name><bio></bio><email>chehovich_elvira@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Suyarkova</surname><given-names>Olesya V.</given-names></name><bio></bio><email>suyarkova_o@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Adygea State University — branch in Belorechensk, Belorechensk, Russia</aff><aff id="aff-2">Kuban Cossack State Institute of Food Industry and Business — branch of the Razumovsky Moscow State University of Technology and Management (First Cossack University), Temryuk, Russia</aff><pub-date date-type="epub" iso-8601-date="2026-07-04" publication-format="electronic"><day>04</day><month>07</month><year>2026</year></pub-date><issue>2</issue><fpage>140</fpage><lpage>143</lpage><history><pub-date date-type="received" iso-8601-date="2026-07-07"><day>07</day><month>07</month><year>2026</year></pub-date></history><permissions><copyright-statement>Copyright © 2026,</copyright-statement><copyright-year>2026</copyright-year></permissions><abstract>The pharmaceutical industry is a vital economic sector, ensuring public health and national security. In the face of global sanctions, a shortage of active pharmaceutical ingredients (APIs), and growing demand for innovative medicines, Russia faces the need for accelerated import substitution and technological sovereignty. This article analyzes current trends in the development of the pharmaceutical industry in the Russian Federation: from structural shifts in production to the introduction of digital technologies, regulatory changes, and the formation of local supply chains. The author identifies the factors that determine the sustainable development of the pharmaceutical industry. Particular attention is paid to the role of government support, including import substitution programs, tax incentives, modernization of production facilities, and the development of research potential. The analysis shows that, despite significant advances in the production of generics and essential drugs, systemic risks persist: a shortage of high-tech substances, low investment in the industry, insufficient integration of pharmaceutical research and industry, and a fragmented regulatory environment.</abstract><kwd-group xml:lang="en"><kwd>import substitution</kwd><kwd>pharmaceutical substances</kwd><kwd>pharmaceutical sovereignty</kwd><kwd>pharmaceuticals</kwd><kwd>drug supply</kwd><kwd>pharmacoeconomics</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>импортозамещение</kwd><kwd>фармацевтические субстанции</kwd><kwd>фармацевтический суверенитет</kwd><kwd>фармацевтика</kwd><kwd>лекарственное обеспечение</kwd><kwd>фармакоэкономика</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Radnaeva S. E., Matskevich I. V., Ukhakshinova E. M. Pharmaceutical industry in Russia: analysis and economic aspects of development. Bulletin of the Buryat State University. Economics and Management. 2020;(3):31—40.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Nezhnikova E. V., Maksimchuk M. V. Pharmaceutical industry in the Russian Federation: problems and development prospects. Bulletin of Peoples&amp;apos; Friendship University of Russia. Series: Economics. 2019;27(1):102—112.</mixed-citation></ref></ref-list></back></article>
